(1 - 12 von 14
)
Katie Price's mum on living with terminal lung disease | Express.co.uk
www.express.co.uk
THE MUM of TV personality and Loose Women star Katie Price tells JANE SYMONS about the reality of living with a terminal lung disease.
Guardian: Campaign launched to raise profile of idiopathic pulmonary fibrosis...
British Lung Foundation says there is a lack of support for those with little-known disease, which kills more people than leukaemia
'My mysterious, incurable lung condition was mistaken for asthma'
www.telegraph.co.uk
Peter Phillips had always felt the occasional respiratory bother.
#ATS Galapagos' GLPG1690 Prevented IPF Lung Function Decline
pulmonaryfibrosisnews.com
Read about the results of Galapagos' Phase 2a trial showing that GLPG1690 prevents lung function decline in IPF patients.
FOCUS: Gefährliche Lungenfibrose : Diese Krankheit ist noch tödlicher als...
Eine Lungenfibrose ist besonders heimtückisch: Durch die Krankheit bildet die Lunge vermehrt Bindegewebe, das Organ versteift und kann den Körper nicht mehr...
GLPG1690 results in IPF published in The Lancet Respiratory
www.globenewswire.com
Dr. Toby Maher et al. describes the FLORA trial results and was ... Dr. Toby Maher, British Lung Foundation Chair in Respiratory Research and ...
Living with Idiopathic Pulmonary Fibrosis (IPF)
www.news-medical.net
By Dr Toby Maher. By Keynote ContributorDr. Toby MaherNational Institute for Health Research Clinician Scientist and. Consultant Physician at ...
NICE says no to expanding scope of Roche’s IPF drug - PharmaTimes
www.pharmatimes.com
Patients in England and Wales with the lung scarring disease idiopathic pulmonary fibrosis will have to wait until their disease has worsened before getting...
Home Page - Israeli Life Sciences Database
israelilifesciences.com
Dr. Toby Maher, Consultant Respiratory Physician at the Royal Brompton Hospital, London, said, "IPF is a progressive and fatal lung disease ...
Nintedanib approvato nella UE per il trattamento della Fibrosi Pol
www.pharmastar.it
Boehringer Ingelheim ha annunciato oggi che la Commissione Europea CE ha approvato nintedanib per il trattamento della fibrosi polmonare idiopatica FPI...
Pulmonary Fibrosis Therapy TD139 Is Effective, Clinical Trial Shows
pulmonaryfibrosisnews.com
Read about the results of a clinical trial that found Galecto's TD139 to be effective against idiopathic pulmonary fibrosis.
Youth no match for older riders...
www.northerndailyleader.com.au
EXPERIENCE won out over youth in Sunday's Tamworth Cycling Club criterium with Brian Bagster and Wayne Toomey leading...
sortiert nach Relevanz / Datum